Compare KPRX & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KPRX | JXG |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 7.5M |
| IPO Year | N/A | N/A |
| Metric | KPRX | JXG |
|---|---|---|
| Price | $2.54 | $4.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 617.6K | 2.5K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $0.23 |
| 52 Week High | $4.18 | $10.29 |
| Indicator | KPRX | JXG |
|---|---|---|
| Relative Strength Index (RSI) | 62.75 | 54.21 |
| Support Level | $1.90 | $3.70 |
| Resistance Level | $2.94 | $4.39 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 65.79 | 72.86 |
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.